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Endonuclease activity) is critically involved in translation as a component of the 40S ribosomal subunit
and participates in the processing of DNA damage, functioning as a damage DNA endonuclease. However, it is
not yet known how the function of rpS3 switches between translation and DNA repair. Here we show that
PKCδ phosphorylates rpS3 resulting in its mobilization in the nucleus to repair damaged DNA.
Phosphorylated rpS3 was only detected in non-ribosomal rpS3 and the repair endonuclease activity of
rpS3 was increased by its phosphorylation. In addition, rpS3 knock-down cells showed more sensitivity to
genotoxic stress than control cells, and this sensitivity was corrected by overexpressed wild-type rpS3 but
not by phosphorylation defective rpS3. In conclusion, we propose that the destiny of rpS3 molecules between
translation and DNA repair is regulated by PKCδ-dependent phosphorylation.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionThe protein kinase C (PKC) family is a group of serine/threonine
kinases composed of at least 12 isoforms. It can be further divided
into classical (α, β , β , and γ), novel (δ, ɛ, η, μ, and θ) and atypical (ζ, λ,
and ι) PKCs, depending on characteristics of the N-terminal regulatory
domains [1]. The PKC family shows tissue- and cell-type-speciﬁc
expression patterns [2,3] and is involved in signal transduction
pathways that control cell growth, differentiation, and death [4–6].
The PKCδ isoform is activated by phorbol esters such as PMA
(phorbol-12-myristate-13-acetate) [7,8] and also in response to
genotoxic stress induced by H2O2, 1-β-D-arabinofuranosylcytosine
(Ara-C), and etoposide [9–11]. In response to DNA damage-induced
apoptosis, PKCδ is activated and cleaved to a 40-kDa catalytic fragment
by caspase-3 [12,13]. Activation of PKCδwould appear to be associated
with tyrosine phosphorylation performed by Src or c-Abl [14–17].
Such tyrosine phosphorylation in response to different stimulations
might regulate the PKCδ kinase activity and its localization and
speciﬁcity [18–20]. A large number of proteins have been identiﬁed as
substrates of PKCδ that localize to different cell compartments [21,22].
Among these are proteins involved in the response to DNA damage
[10,13,23,24].
Ribosomal protein S3 (rpS3) is a component of the 40S ribosomal
subunit and is critically involved in translation. However, rpS3 is a
multi-functional protein like several other ribosomal proteins [25,26]
in the processing of UV-induced and other DNA damages, functioning
as a damage DNA endonuclease [27,28]. Furthermore, rpS3 is involved
in apoptosis [29], transcription as a p65-binding component of NF-κB
complexes in the TCR-stimulated lymphocytes [30] and in invasion by82 2 927 9028.
l rights reserved.blocking the ERK pathway and MMP-9 secretion [31]. The stability of
rpS3 is regulated by Hsp90 chaperoning activity [32].
Thus rpS3 appears to be involved in transcription, translation,
DNA repair, invasion and apoptotic pathways, probably depending
upon different post-translational modiﬁcations. Although it is not
yet known which modiﬁcation switches the function of rpS3, we
have focused on the rpS3 phosphorylation because the ribosomal
incorporation of rpS3 is regulated by phosphorylation status in yeast
[33].
Here, we show that PKCδ interacts with rpS3 in vivo and in vitro,
and phosphorylates the protein. Activation of PKCδ using PMA or
genotoxins markedly increased rpS3 phosphorylation and this
phosphorylation was only detected in the non-ribosomal rpS3.
Additionally, the repair endonuclease activity of rpS3 was increased
by approximately three-fold after phosphorylation.
2. Materials and methods
2.1. Reagents and antibodies
Protein A-Sepharose and calf intestinal alkaline phosphatase (CIP)
were purchased from Roche Molecular Biochemicals (Mannheim,
Germany). Anti-GST (sc-459), anti-PKCδ (sc-937), anti-p38 (sc-7149),
anti-Src (sc-5266), anti-HA (hemaglutinin) (sc-7392), anti-PARP
(sc-8007), anti-His (sc-8036), and anti-phospho-Thr (sc-5267) anti-
bodies were obtained from Santa Cruz Biotechnology, Inc. (Santa
Cruz, CA). Anti-phosphoserine/threonine antibody (612548) was
purchased from BD Bioscience (San Diego, CA). Anti-phospho-p38
(9216) was purchased from Cell Signaling. Anti-FLAG (F-3165) was
purchased from Sigma. Anti-phospho-Ser (61-8100) was purchased
from Zymed Laboratories, Inc. (San Francisco, CA). Anti-α-tubulin
(LF-PA0146) was purchased from Lab Frontier. Anti-human rpS3 was
Fig. 1. PKCd interacts with and phosphorylates rpS3. (A) HEK293T cells were transfected with GFP or GFP-tagged rpS3. Cell lysates were subjected to immunoprecipitationwith PKCδ
antibody and subjected to immunoblot analysis. (B) HEK293T cell lysates were immunoprecipitated with PKCδ (right panel) or rpS3 (left panel) antibodies, and the precipitates were
immunoblotted with PKCδ and rpS3 antibodies. Pre-immune rabbit serum (PIRS) was used as a negative control. (C) The puriﬁed His-PKCδwas incubated with GST bead-bound GST
or GST-rpS3. Bound His-PKCδwas detected by immunoblotting. (D) HEK293T cells were treated with PMA (100 ng/ml), H2O2 (100 μM), or Ara-C (10 μM) for 30 min. Total cell extracts
were prepared and immunoprecipitated with PKCδ antibody, and the precipitate was monitored for the presence of PKCδ or rpS3 by immunoblotting. (E) HEK293T cell lysates were
immunoprecipitated with PKCδ antibody, and an in vitro kinase assay was performed using puriﬁed His-rpS3. Bead only was used a negative control. Asterisks indicate PKCδ
autophosphorylation. (F) HEK293T cells were transfected with the HA-tagged PKCδ WT or DN (K376R) form (upper panel). Total cell lysates were immunoprecipitated with HA
antibody and subjected to an in vitro kinase assay. Proteins were analyzed by 10% SDS-PAGE and subsequent immunoblotting (lower left panel) or autoradiography (lower right panel).
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purchased from Pierce (34078). The glutathione-Sepharose 4B was
obtained from Amersham Pharmacia Biotech (17-0756-01). H2O2
were purchased from Sigma. PP2, PMA, Ara-C, rottlerin, okadaic acid,
and Gő6976 were obtained from Calbiochem (EMD Biosciences, La
Jolla, CA). Bacterial alkaline phosphatase (BAP) was purchased from
Invitrogen.
2.2. In vitro kinase assay
An E. coli expression vector for C-terminal 6xHis-rpS3 was
constructed using expression vector pET21a (Novagen), and the fusion
protein was puriﬁed on Ni-NTA agarose (Qiagen). Phosphorylation of
recombinant His-rpS3 was carried out using endogenous or recombi-
nant PKCδ. Cell lysates were immunoprecipitated with an anti-PKCδ
antibody, and immunoprecipitates werewashed three timeswith lysis
buffer and two times with kinase reaction buffer (20 mM Tris–Cl, pH
7.5, 5 mMMgCl2, 0.5 mM EGTA, 1 mM DTT, 1.5 μM Phosphatidylserine,1mMNaF, 0.1 mMNa3VO4, and 0.1% NP-40). The reactionmixture was
initiated by the addition of 1.0 μCi of [γ-32 P] ATP and His-rpS3 or
Histone H1 substrate and incubated at 30 °C. After 30 min of
incubation, the reaction was stopped by the addition of 20 μl of 2 ×
SDS-sample buffer and subjected to SDS-PAGE. After the gel was dried,
phosphorylated protein was visualized with a BAS2500 imaging
analyzer (Fujiﬁlm, Tokyo, Japan).
2.3. GST pull-down assay
We used the GST gene fusion system (Amersham Biosciences) to
generate GST-rpS3 fusion protein. For GST pull-down assays, fusion
proteins were adsorbed to glutathione-Sepharose 4B beads. His-
puriﬁed PKCδ was then incubated with GST or GST fusion protein in
the binding buffer (50 mM Tris–Cl, pH 7.5, 150 mM NaCl, 1 mM EDTA,
0.3 mM DTT, 0.1% NP-40, and protease inhibitors). The binding
reaction was incubated for 2 h at 4 °C, and then the beads were
washed three timeswith the same buffer and the bound proteins were
397T.-S. Kim et al. / Biochimica et Biophysica Acta 1793 (2009) 395–405subjected to 10% SDS-PAGE analysis. Proteins were detected by
immunoblot analysis.
2.4. Cell fractionation
To prepare the nuclear and cytosol protein extracts, cells were
seeded and cultured to 90% conﬂuency on 60-mm dishes. Cells
were then treated with appropriate drugs for several different
amounts of times indicated. Following washing, cells were
harvested and collected by centrifugation. Cells were suspended
into buffer A (10 mM HEPES, pH 7.9, 50 mM NaCl, 1 mM DTT,
0.1 mM EDTA, and protease inhibitors) for 20 min on ice. An equal
volume of buffer B (buffer A+0.1% NP-40) was then added and the
suspension was allowed to sit for 20 min on ice. Following
centrifugation, the supernatant (cytosol fraction) was collected
and subjected to centrifugation at 5000 ×g for 2 min to remove
cellular debris. The nuclear pellet was washed two times with
buffer A and resuspended using buffer C (10 mM HEPES, pH 7.9,
400 mM NaCl, 1 mM DTT, 1 mM EDTA, 1 mM EGTA). The nuclear
fractions were cleared of debris by centrifugation at 13,000 rpm for
15 min at 4 °C. Protein concentrations were measured using
Bradford reagent (Bio-Rad).
2.5. Ribosome fractionation
Sucrose density gradient fractionation of ribosomes was per-
formed as described previously [34]. Cells were harvested after the
addition of cycloheximide (50 μg/ml) to the medium for 25 min. Then,
for the collection of ribosomal and non-ribosomal fractions, the
lysates were centrifuged at 10,000 ×g at 4 °C for 15 min in order to
remove themitochondria and cell debris. The supernatant was layered
over a 20% (w/v) sucrose cushion and centrifuged in a swinging bucket
SW55Ti rotor at 149,000 ×g for 2 h. The pellet containing ribosomes
and the upper portions of the non-ribosomal supernatants were
collected. The ribosomal pellets were resuspended in the lysis buffer,
after which immunoblotting was performed.
For immunoprecipitation of ribosome pellets under denaturing
conditions, the pellets were solubilized using a previously described
buffer [35].
2.6. siRNA and transfection
Two different rpS3-speciﬁc siRNA oligos were designed homo-
logous to the rpS3 mRNA consensus sequence. The sequences of the
siRNAs for rpS3 gene knockdown are as follows: siRPS3-203, 5′-CTG-
ACTGCTGTAGTTCAGA-3′ and siRPS3-635, 5′-CCCAAAGATGAGATA-
CTGC-3′. Small-interfering RNAs against rpS3, AccuTarget™ GFP,
AccuTarget™ Src and AccuTarget™ PKCδ (Bioneer, Daejeon, Republic
of Korea) were transfected using Lipofectamine™ RNAiMAX transfec-
tion reagent (Invitrogen, USA).
To create siRPS3-635-resistant wild-type and double mutant
(rpS3S6A, T221A) FLAG-rpS3 expression vectors, two silent mutations
(5′-CCCAAGGACGAGATACTGC-3′) were introduced in the region
complementary to siRPS3-635 using site-directed mutagenesis
(underlined letters indicate the silent mutations).
2.7. MTT assay
Proliferation was assessed with the MTT method. Cells (2×104
cells/well) were reverse-transfected with siRNA, plated (in triplicate)
in 96-well plates. After 48 h, cells were treated with or without H2O2
at various concentrations for 24 h. Then, 10 μl of MTT reagent were
added and the cells were incubated for another 3 h at 37 °C. The
absorbance at 595 nm was measured using a microplate reader.
Statistically signiﬁcant differences between data sets were deter-
mined using paired Student's t test.3. Results
3.1. PKCδ interacts with rpS3 in vivo and in vitro
It has been already identiﬁed that human rpS3 has several
phosphorylation sites [36–39], but it is mostly unknown which
kinases are involved in the rpS3 phosphorylation. To investigate the
candidate protein kinases, we analyzed the amino acid sequence of
rpS3 by phosphorylation prediction programs (NetPhos, KinasePhos,
PredPhospho, and Prosite). In this study, many putative phosphoryla-
tion sites on rpS3 have been identiﬁed and several of them suggested
that PKCδ is a strong candidate for rpS3 phosphorylation.
To demonstrate that PKCδ interacts with rpS3, HEK293T cells were
transfected with GFP or GFP-tagged rpS3 and a PKCδ immunopreci-
pitation showed that PKCδ interacted with ectopically-expressed rpS3
(Fig.1A). A similar immunoprecipitation assay using endogenous PKCδ
and rpS3 also indicated that PKCδ interactedwith rpS3 in vivo (Fig.1B).
In the GST pull-down assay, puriﬁed His-PKCδ only interacted with
GST-bound rpS3, and not with GST alone (Fig. 1C), showing that PKCδ
interacts with rpS3 directly. To test whether this interaction is related
to DNA damage, we performed an immunoprecipitation assay using
the PKCδ activators, PMA, H2O2, and Ara-C. It was well known that
PKCδ activators strengthen the interactions between PKCδ and its
substrates [10,40,41]. These activators increase the interaction of PKCδ
with rpS3 (Fig. 1D and Supplementary Fig. S1), suggesting that the
interaction is strengthened in the presence of PKCδ activators.
3.2. PKCδ phosphorylates rpS3
To test if PKCδ phosphorylates rpS3, we performed in vitro kinase
assay using PKCδ immunoprecipitates. The result showed that rpS3
was phosphorylated in the presence of PKCδ (Fig. 1E, lane 3). To
conﬁrm this, we tested rpS3 phosphorylation using wild-type (WT)
and dominant-negative, K376R, (DN) PKCδ (Fig. 1F, upper panel)
[42–44]. HEK293T cells were transfected with HA-tagged PKCδWT or
DN plasmid. This phosphorylation was disappeared in the mutant
PKCδ-K376R (Fig. 1F) indicating that PKCδ interacts with and
phosphorylates rpS3 in vivo.
3.3. RpS3 phosphorylation is regulated by PKCδ activity
HEK293T cells were transfected with GST-rpS3 and after 24 h, cells
were pretreated with 100 nM okadaic acid (OA), followed by PMA in a
dose-dependent manner. GST-rpS3 was immunoprecipitated and
immunoblotted using anti-pSer or anti-pThr antibodies. RpS3 phos-
phorylation was increased by PMA in a dose-dependent manner
(Fig. 2A). Also, rpS3 phosphorylation was increased by PMA in a time-
dependent manner (Supplementary Fig. S2A). To extend these
ﬁndings further using an in vitro kinase assay, HEK293T cells were
treated with PMA. The PKCδ immunoprecipitates were mixed with
Histone H1 (Fig. 2B, lanes 1–3) or His-rpS3 (Fig. 2B, lanes 4–6). The
result showed that the increased pattern of rpS3 phosphorylation is
the same as that of histone H1, which was increased upon treatment
with PMA.
To show that PMA-induced rpS3 phosphorylation is mediated by
PKCδ and that inhibition of PKCδ decreases the level of phosphorylated
rpS3, HEK293Tcells were treatedwith PMA in the presence or absence
of rottlerin, a selective inhibitor of PKCδ [45]. As shown in Fig. 2C, rpS3
phosphorylation was enhanced by PMA. However, pretreatment with
rottlerin blocked the PMA-induced rpS3 phosphorylation (Fig. 2C). To
show the PKCδ-speciﬁc rpS3 phosphorylation, HEK293T cells were
transfected with HA-tagged PKCδ plasmid. After 24 h, cells were
stimulated with PMA in the presence or absence of rottlerin or
Gő6976, a selective inhibitor of the conventional PKCs. As shown in
previous data, the level of phosphorylated rpS3 was increased by PMA
(Fig. 2D, lane 4). Furthermore, phosphorylation of rpS3 was
Fig. 2. Phosphorylation of rpS3 is regulated by PKCd activity. (A) HEK293Tcells were transfectedwith GST-rpS3. After 24 h, cells were pretreatedwith 100 nMOA for 10min, and were
then incubated with the indicated concentrations of PMA for 30 min. The cells were lysed and GST-rpS3 proteins were pulled down using GST beads. Phospho ERK was used to verify
the effect of PMA. (B) HEK293T cells were incubated in the presence or absence of PMA (100 ng/ml) for 30 min. PKCδ kinase assay was performed using histone H1 or His-rpS3.
Asterisks indicate PKCδ autophosphorylation. Beads were used a negative control. (C) HEK293T cells were treated with PMA for 30 min with or without rottlerin pretreatment. The
PKCδ kinase assay was performed using His-rpS3. (D) HEK293T cells were transfected with HA-tagged PKCδ. After 24 h, cells were treated with rottlerin (5 μM; lane 5 and 20 μM;
lane 6) or 6 nM Gő6976 (lane 7) or left untreated for 30 min. Cells were then stimulated with PMA for 30 min as indicated. HA-PKCδwas immunoprecipitated, and a kinase assay was
performed using Histone H1 (lane 2) or His-rpS3 (lanes 3–7) as a substrate. (E) HEK293T cells were treated for 30 minwith 100 μMH2O2. (F) Cells were stimulated with 100mMH2O2
for 30minwith or without rottlerin (10mM) pretreatment for 30min as indicated. (G) HEK293Tcells were pretreated for 30minwith rottlerin in a dose-dependent manner, followed
by treatment with 10 mM Ara-C for 30 min.
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conversely, it was not affected by Gő6976 (Fig. 2D, lane 7 and
Supplementary Fig. S2B). These ﬁndings demonstrate that PKCδ is the
kinase involved in rpS3 phosphorylation.
We also examined whether treatment of cells with DNA-damaging
agents is associated with a PKCδ-dependent phosphorylation of rpS3.
HEK293T cells were exposed to 100 μMH2O2 for 30 min and analyzed
by the PKCδ kinase assay. An increase in rpS3 phosphorylation was
found and this effect was dependent upon H2O2 concentration and
time (Fig. 2E and Supplementary Fig. S2C, D). In addition, HEK293T
cells were treated with Ara-C for 30 min, the phosphorylation of rpS3
by PKCδ also increased in a dose-dependent manner (SupplementaryFig. S2E). Then, we tested whether rottlerin affects the levels of
phosphorylated rpS3 in cells treated with H2O2 or Ara-C. RpS3
phosphorylation was increased by H2O2 or Ara-C treatment, but was
inhibited by pretreatment with rottlerin (Fig. 2F and G). Taken
together, these data suggest that DNA-damaging agents induce the
rpS3 phosphorylation by PKCδ activators like PMA.
3.4. Src is responsible for tyrosine phosphorylation and activation of
PKCδ
It has been known that Src is an upstream kinase of PKCδ that
regulates its activation through tyrosine phosphorylation [46,47]. To
399T.-S. Kim et al. / Biochimica et Biophysica Acta 1793 (2009) 395–405conﬁrm the co-relationship between Src and rpS3, we used cells
transiently transfected with myc-tagged Src constructs, WT, DN
(K296R/Y528F), or CA (Y529F), and compared PKCδ phosphorylation
by immunoblot analysis using pTyr antibody (Fig. 3A). Tyrosine
phosphorylation of PKCδ was detected at signiﬁcant levels in cells
transfected with constitutively active Src (Y529F) plasmids. We
further observed that tyrosine phosphorylation of PKCδwas increased
by treatment with PMA, H2O2, or Ara-C (Fig. 3B). When HEK293T cells
were treated with increasing concentrations of PP2 (Src tyrosine
kinase inhibitor), the interaction between Src and PKCδwas abrogated
(Fig. 3C). In order to verify whether Src activity is important for the
PKCδ-induced rpS3 phosphorylation, we performed an in vitro kinase
assay using puriﬁed His-rpS3. HEK293T cells were stimulated with
PMA, H2O2, or Ara-C in the presence of PP2 pretreatment. As expected,
the levels of rpS3 phosphorylation by PKCδ were increased (Fig. 3D,
lanes 2, 4, and 6) except rpS3 in cells pretreated with PP2 (Fig. 3D,
lanes 3, 5, and 7). Then, we treated cells with PP2 in a dose-dependent
manner, then stimulated cells for 30 min with H2O2, PMA, or Ara-C
(Supplementary Fig. S3). All the results showed that rpS3 phosphor-
ylation was diminished by increased PP2 concentration, whereas itFig. 3. Src is involved in the rpS3 phosphorylation via PKCd activation. (A) HEK293T cells wer
immunoprecipitated with PKCδ antibody and analyzed for tyrosine phosphorylation. (B) HEK
which cell lysates were immunoprecipitated, resolved by SDS-PAGE, and then subjected to
30 minwith PP2 in a dose-dependent manner as indicated. Cell lysates were immunoprecipit
with PMA (100 ng/ml), H2O2 (100 μM), or Ara-C (10 mM) for 30minwith or without PP2 (2 μM
kinase assay using His-rpS3 as a substrate. The amounts of PKCδ used in immunoprecipit
Coomassie staining. (E) HEK293T cells were transfected with siRNAs targeting the indicated
lysates were immunoprecipitated with rpS3 antibody, resolved by SDS-PAGE, and then subj
with GFP or Src siRNA, were treated with 100 μMH2O2 for 30min, after which PKCδwas imm
as a substrate. Total extracts were immunoblotted with indicated antibodies.was increased by H2O2, PMA, or Ara-C alone (Supplementary Fig. S3).
To further strengthen our ﬁndings, we used speciﬁc siRNAs to
suppress Src or PKCδ expression. The siRNA-transfected cells were
stimulated with H2O2 for 30 min, and then fractionated nuclear
proteins were immunoprecipitated with rpS3 antibody. Interestingly,
in the presence of H2O2, decreased phosphorylation of rpS3 was
observed in PKCδ or Src knockdown cells (Fig. 3E, lanes 3 and 4) as
compared with control cells (Fig. 3E, lane 2). We also obtained the
same result in the PKCδ kinase assay. RpS3 phosphorylation was
increased by H2O2 only in the siGFP-transfected control cells (Fig. 3F,
lane 2), but not in the siSrc-transfected cells (Fig. 3F, lane 3).
Collectively, these data indicate that PKCδ-dependent rpS3 phospho-
rylation is regulated by Src kinase.
3.5. Identiﬁcation of PKCδ phosphorylation sites of rpS3
RpS3 contains eight putative sites based on the PKCδ consensus
motif of X–S/T–X–R/K, and rpS3 constructs were prepared with
serine/threonine to alanine substitution. PKCδ kinase assay then
indicated that at least two residues, serine 6 and threonine 221, aree transfected with myc-tagged Src (WT, DN, and CA forms). After 24 h, cell lysates were
293T cells were treated with PMA (100 ng/ml), H2O2 (100 μM), and Ara-C (10 mM), after
immunoblot analysis with pTyr or PKCδ antibodies. (C) HEK293T cells were treated for
ated with PKCδ antibody and resolved by 10% SDS-PAGE. (D) HEK293T cells were treated
) pretreatment for 30 min as indicated. The activity of PKCδwasmeasured by an in vitro
ation and His-rpS3 used in the kinase assay were monitored by immunoblotting and
genes. After 48 h, cells were treated with 100 μM H2O2 for 30 min, after which nuclear
ected to immunoblot analysis with indicated antibodies. (F) HEK293T cells, transfected
unoprecipitated from cell extracts and then performed PKCδ kinase assay using His-rpS3
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(S6A, T221A) was hardly phosphorylated relative to the rpS3 single
point mutants (Fig. 4B). We also performed immunoblot analysis to
conﬁrm this result. HEK293T cells were transfected with FLAG-tagged
rpS3 wild-type (WT) or double-mutant (6 and 221) and then
immunoprecipitated with FLAG antibody. As shown in Fig. 4C, phos-
phorylated rpS3 was only detected with the wild-type rpS3.
3.6. Phosphorylated rpS3 is detected only in the non-ribosomal fraction
In order to deﬁne which form of rpS3, whether a ribosome-
incorporated form or a free non-ribosomal form, is phosphorylated by
PKCδ, we performed ribosome fractionation using a sucrose cushion.
Phosphorylation of rpS3 was only detected in the supernatant
fraction, indicating that non-ribosomal rpS3 is phosphorylated by
PKCδ in vivo (Fig. 4D, lanes 1 and 2). Additionally, the phosphorylation
of non-ribosomal rpS3 was increased in cells treated with PMA
(2.5-fold increased) and decreased with rottlerin (3.2-fold decreased)
(Fig. 4D, lanes 3–6). To test whether rpS3 phosphorylation is involved
in ribosomal incorporation of rpS3, cells were transfected with FLAG-
rpS3 wild-type or double-mutant (6 and 221) and subjected to ultra-
centrifugation to divide it into soluble and ribosome-incorporated
forms. The mutant rpS3 was detected mostly in the ribosomal fraction
but signiﬁcant amounts of wild-type rpS3 existed in the soluble form
compared to the mutant rpS3 (Fig. 4E). The percentage of wild-type
FLAG-rpS3 was approximately 30% in soluble (S) and 70% in pellet (P)
fractions whereas mutant FLAG-rpS3 was approximately 3% in soluble
(S) and 97% in pellet (P) fractions. In conclusion, serine 6 andFig. 4. Ser6 and Thr221 of free non-ribosomal rpS3 are phosphorylated by PKCd. (A) PKCδwa
wild-type (WT) or point mutants and [γ-32P] ATP. Phosphorylated His-rpS3 was identiﬁed b
(B) HA-PKCδwas immunoprecipitated, after which a PKCδ assay was performed using His-rp
rpS3 wild-type (WT) or double-mutant (6,221). FLAG immunoprecipitates were resolved by 1
or DMSO as indicated. After 2 h, cells were lysed and cell lysates were subjected to ultracent
described in Materials and methods. The isolated supernatant and pellet were subjected to im
JNK antibodies. JNK antibody was used as non-ribosomal fraction control. (E) HEK293T cells w
24 h, cells were harvested, lysed, and ultracentrifuged as described in Materials and methods
by 10% SDS-PAGE and analyzed by immunoblot analysis.threonine 221 on rpS3 are the major sites that can be phosphorylated
by PKCδ and this phosphorylation affects the ribosome localization of
rpS3.
3.7. PKCδ-dependent phosphorylation of rpS3 affects its
nuclear localization
When cell lysates were divided into cytosolic and nuclear fractions
and immunoprecipitation was carried out using rpS3 antibody, the
interaction between rpS3 and PKCδwas only detected in the cytosolic
fraction. Furthermore, this interaction was signiﬁcantly increased by
PMA or Ara-C treatment (Fig. 5A). Apparently, non-ribosomal soluble
rpS3 is phosphorylated by PKCδ in the cytosol. Tubulin was used as a
cytosol marker, while PARP was used as a nuclear marker.
Since all the ribosomal proteins must translocate from the cytosol
to the nucleus for ribosome biogenesis [48,49] and the localization of
several proteins is modulated by PKCδ-dependent phosphorylation
[50–52], we examined how rpS3 phosphorylation affect its intracel-
lular distribution. HEK293T cells were transfected with HA-tagged
PKCδ WT, PKCδ CA (constitutively active form), or empty vector and
then the subcellular localization of rpS3 was examined. Nuclear rpS3
was increased by the transfection of PKCδ WT (Fig. 5B, lane 2).
However, the transfection of PKCδ CA caused a greater increase in
nuclear rpS3, indicating that constitutively active PKCδ exerted a
stronger inﬂuence on the localization of rpS3 (Fig. 5B, lane 3).
Furthermore, PMA treatment resulted in an increase of rpS3 located in
the nucleus, whereas rottlerin led to a reduction of nuclear rpS3
(Fig. 5C) and both of these effects occurred in a time-dependents immunoprecipitated from cell extracts and then incubated with recombinant His-rpS3
y autoradiography. Equal amounts of substrates were monitored by Coomassie staining.
S3 WT and point mutants as a substrate. (C) HEK293T cells were transfected with FLAG-
0% SDS-PAGE. (D) HEK293T cells were treated with PMA (100 ng/ml), rottlerin (10 mM),
rifugation for isolation of the non-ribosomal supernatant (S) and ribosome pellet (P) as
munoprecipitationwith rpS3 antibody and immunoblot analysis with pSer/Thr, rpS3 or
ere transfected with FLAG-tagged rpS3 wild-type (WT) or double-mutant (6,221). After
. Total cell lysate (L), soluble fraction (S), and ribosome pellet (P) samples were resolved
Fig. 5. Subcellular localization of phosphorylated rpS3. (A) HEK293T cells were treated with PMA or Ara-C for 30 min and then fractionated to cytosol (C) and nuclear (N) fractions.
Both fractions were immunoprecipitated with rpS3 antibody. Tubulin and PARP antibodies were used as fraction controls for cytosol and nuclear fractions. (B) HEK293T cells were
transfected with empty vector (E.V), HA-PKCd wild-type (WT), or constitutively active (CA) form of the plasmid. After 24 h, cells were fractionated as described in Materials and
methods. (C) HEK293T cells were treated for 2 h with 100 ng/ml PMA or 10 μM rottlerin as indicated. (D–E) HEK293T cells were treated with rottlerin (D) and PMA (E) for times
indicated and fractionated proteins were submitted to immunoblotting using rpS3, tubulin, and PARP antibodies. (F) HEK293T cells were pretreated with rottlerin (10 μM), U0126
(10 μM), and PD98059 (40 μM) for 3 h, thenwith 100 μMH2O2 for 1 h. Phospho-ERKwas used to verify the effect of drug treatment. (G) H2O2-treated cells were harvested at described
times. Fractionated proteins were immunoprecipitated with rpS3 antibody and immunoblotted with indicated antibodies.
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transiently transfected with a constitutively active form of PKCδ
(Supplementary Fig. S4). To test whether PKCδmight have acted with
the downstream kinases through the PKCδ/MEK/ERK pathway [53,54],
we used inhibitors of PKCδ (rottlerin) and MEK (U0126 and PD98059)
(Fig. 5F). Rottlerin blocked the increase of nuclear rpS3 by H2O2,
whereas U0126 and PD98059 had no effect. And phosphorylated rpS3
is actually increased in the nucleus by H2O2 (Fig. 5G). From these
results, we conclude that the nuclear localization of rpS3 is not
dependent uponMEK and that there is a link between PKCδ activation
and nuclear localization of rpS3.
3.8. Phosphorylation of rpS3 has an effect on its DNA repair
endonuclease activity and cell viability
To measure the basal rpS3 endonuclease activity, we performed a
plasmid-nicking assay using puriﬁed His-rpS3 from E. coli. The results
show that rpS3 has an endonuclease activity on depurinated DNA(AP-DNA), but very little on normal DNA (N-DNA) (Supplementary
Fig. S5A and B). To examine the effect of phosphorylation of rpS3 upon
its depurinated DNA endonuclease activity, we performed an in vitro
kinase assay using PKCδ immunoprecipitates in the presence or
absence of ATP to make phosphorylated rpS3, followed by a plasmid-
nicking assay in a time-dependent manner. The endonuclease activity
of phosphorylated rpS3 in the presence of ATP is higher than that of
unphosphorylated one in the absence of ATP (Fig. 6A). The diagram
shows the endonuclease activity is higher in phosphorylated rpS3
than in unphosphorylated rpS3. We also obtained the same result on
UV-irradiated DNA (Supplementary Fig. S5C). Taken together, these
results indicated that the endonuclease activity of rpS3 is increased by
its phosphorylation.
To strengthen the above results, we used two phosphatases, calf
intestinal alkaline phosphatase (CIP) and bacterial alkaline phospha-
tase (BAP). His-rpS3 was phosphorylated as described previously, and
then treated it with CIP (Fig. 6B) or BAP (Supplementary Fig. S5D). The
endonuclease activity of dephosphorylated rpS3 was decreased to the
Fig. 6. Phosphorylated rpS3 has an increased DNA endonuclease activity. (A) Depurinated DNAwas incubated with unphosphorylated (−ATP) or phosphorylated (+ATP) rpS3 at 37 °C
for times indicated. The histogram shows the relative nicking activity between phosphorylated (black bars) or unphosphorylated (white bars) rpS3. The mean and standard deviation
of the repair activity from ﬁve different experiments are given. N; nicked DNA, S; Supercoiled DNA. (B and C) Depurinated DNA (B) and UV-irradiated DNA (C) weremixedwith intact,
phosphorylated, or dephosphorylated (using CIP) rpS3 for 1 h at 37 °C. (D) Phosphorylated rpS3 or rpS3m (rpS3S6A,T221A) was incubated with depurinated DNA at 37 °C for the
indicated amounts of time and themixturewas separated in 1% agarose gel. (E) HEK293T (left) and HT1080 (right) cells were transfectedwith control siGFP or rpS3 siRNA. Cell lysates
were immunoblotted with rpS3 and tubulin antibodies. (F) Cell proliferationwas assessed byMTTassay. The data are from four separate experiments and showmean±s.e.m. of three
independent experiments. ⁎Pb0.05 compared with unstimulated controls. (G) HT1080 cells were co-transfected with siRNA and FLAG, FLAG-rpS3WTR or MTR, siRPS3-635 resistant
construct. As described in (F), cell proliferation was tested by MTT analysis (⁎Pb0.05). The data are from four separate experiments and show mean±s.e.m. of four independent
experiments. Right panel showed western blot analysis in siRNA and plasmid DNA transiently transfected cells.
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irradiated DNA (Fig. 6C). To investigate whether PKCδ-dependent
phosphorylation is involved in the increased rpS3 endonuclease
activity, we compared the endonuclease activity between wild-type
rpS3 and double mutant rpS3m (S6A, T221A), a non PKCδ-mediated
phosphorylated mutant (Fig. 4). We tested the endonuclease activity
between rpS3 and rpS3m after kinase reaction using PKCδ immuno-
precipitates. As shown in Fig. 6D, phosphorylated wild-type rpS3 had
a higher activity than nonphosphorylated rpS3m on depurinated DNA.
These results indicate that the PKCδ-dependent phosphorylations onthe serine 6 and threonine 221 residues of rpS3 are critical for the
endonuclease activity of rpS3.
To assess the potential role of rpS3 endonuclease activity in cell
viability, we used RNA interference to knock down the protein levels
of rpS3. HT1080 cells were transfected with siRNAs. After 48 h, both of
the rpS3 siRNAs signiﬁcantly decreased the level of endogenous rpS3,
while the control GFP siRNA had no effect (Fig. 6E). RpS3 knockdown
in the HT1080 cells resulted in a signiﬁcant reduction in cellular
viability compared with the control GFP siRNA (Fig. 6F). This result is
not due to a decreased protein synthesis [30].
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resistant FLAG-rpS3 to conﬁrm that this phenomenon is speciﬁcally
dependent on the enzyme activity of rpS3. HT1080 cells were
cotransfected with siRPS3-635 and wild-type FLAG-rpS3 (WTR) or
mutant FLAG-rpS3S6A, T221 (MTR). As shown in Fig. 6G, cell viability
was mostly complemented by WTR but not by MTR. These results
indicated that PKCδ-dependent phosphorylated rpS3 has an increased
endonuclease activity and that the endonuclease activity of rpS3 is
critical for a cell survival in the stress condition.
4. Discussion
RpS3 is a substrate of PKCδ and is phosphorylated on serine 6 and
threonine 221 in response to PMA or DNA-damaging agents. These
two residues appear to be important for controlling the function of
rpS3, because phosphorylated rpS3 was only detected in the free non-
ribosomal form, remaining undetected in the ribosome-incorporated
form.
While the concept that free ribosomal proteins and ribosome-
assembled ribosomal proteins are regulated by distinct, highly
integrated signaling pathways has been proposed, identiﬁcation of a
speciﬁc regulator that controls ribosomal proteins in response to
different stresses or chemicals has proven difﬁcult. Nevertheless,
many ribosomal proteins are phosphorylated and this phosphoryla-
tion is involved in ribosomal association and function [55–57].
Even-though very little residual level of phosphorylation was
detected in case of rpS3 double-mutant (rpS3S6A, T221A), there is still a
possibility that another kinase may be associated with PKCδ or
another minor phosphorylation site. Therefore, we used several
inhibitors and activators to conﬁrm the PKCδ-speciﬁc effects on rpS3
phosphorylation and to rule out the contamination of other PKCs. The
fact that rpS3 phosphorylation was not affected by Gö6976 excludes
the contamination of conventional isoforms (Fig. 2D and Supplemen-
tary Fig. S2B). PMA, an activator of novel PKCs such as PKCδ, is known
that it cannot activate atypical PKCs. Therefore, our results could
exclude both conventional and atypical PKC isoforms. It was
previously identiﬁed that both PKCθ and PKCη isoforms are not
expressed in normal HEK293 cells [58,59]. Furthermore, our data
showed that rpS3 phosphorylation was decreased by either rottlerin
treatment or PKCδ knock-down (Figs. 2 and 3). Therefore, it can be
concluded that PKCδ speciﬁcally phosphorylates rpS3.
It has been reported that ERK phosphorylates rpS3 [36] and that
the nuclear localization of rpS3 in oxidative stress is regulated by ERK
[60]. Moreover, rpS3 (T42D) exists in the nucleus irrespective of
oxidative stress. However, we observed a different result. The enrichedFig. 7. Schematic model describing the regulation of rpS3 upon exposure to genotoxic stress.
on PKCd. Activated PKCδ interacts with and phosphorylates non-ribosomal free rpS3 in the cy
lated rpS3 remains in the nucleus to take part in DNA repair processes.nuclear localization of rpS3 was blocked by rottlerin but not by MEK
inhibitors (Fig. 5F) and there was no difference in rpS3 localization
between wild-type and a T42D mutant (Supplementary Fig. S6).
Therefore, we propose that PKCδ, but not ERK, regulates the nuclear
localization of rpS3 after genotoxic stress.
Moreover, we conﬁrmed that PKCδ-dependent phosphorylation of
rpS3 affects its incorporation into the ribosome. Mutagenic analysis of
serine 6 or threonine 221 on rpS3 demonstrated the importance of
these residues in the fate of rpS3 in terms of ribosome incorporation
and DNA repair. Interestingly, other groups suggested that phospho-
rylation of ribosomal proteins controls their interactions with riboso-
mes [55,57].We demonstrated that the level of phosphorylated rpS3 is
increased by DNA-damaging agents and is accumulated in the nucleus.
Also, in yeast, it has been reported that phosphorylated rpS3 cannot
integrate stably into ribosomes in the nucleus [33]. These indicate
that, like other proteins involved in DNA repair [61–63], phosphory-
lated rpS3 is associated with the DNA repair process.
Our data also show that the phosphorylation of rpS3 occurred only
in the non-ribosomal fraction, indicating that unmodiﬁed rpS3 is
assembled and exists in the ribosome. Zhang et al. postulated a
swinging model of rpL11 [64]. Although we do not know that is appli-
cable to all the ribosomal proteins, rpS3 is supposed to freely associate
and dissociate with ribosome.
It has been previously suggested that a distinct pool of rpS3
sequestered from ribosome-associated rpS3 exists in the cytosol [30].
We entirely agree with the hypothesis from the functional point of
view. It has been identiﬁed that rpS3 has multiple functions not only
in protein translation but also in DNA repair, invasion inhibition,
apoptosis, and NF-kB-dependent transcription [27–31]. We consider
that these roles besides protein translation are mediated by free non-
ribosomal rpS3 and these functional changes of rpS3 are regulated by
post-translational modiﬁcations such as phosphorylation, neddyla-
tion and ubiquitination [32,36,65,66]. We showed that the proportion
of non-ribosomal FLAG-rpS3 is about 30% of total cellular FLAG-rpS3
(Fig. 4E). Even if there is some difference from the result reported by
Wan et al. [30], it could be caused by different methods for the
ribosome fractionation.
In conclusion, our study has elucidated that the functional change
of rpS3 between a ribosomal component and a non-ribosomal protein
is regulated by PKCδ-dependent phosphorylation. The results pre-
sented here suggest a model for the role of rpS3 in conjunction with
PKCδ (Fig. 7). Src tyrosine kinase activated by DNA damage
phosphorylates and activates PKCδ. Then, activated PKCδ phospho-
rylates free non-ribosomal rpS3 in the cytoplasm. Even though both
unphosphorylated and phosphorylated rpS3 are able to exist in theSrc tyrosine kinase is activated by genotoxic stress and phosphorylates tyrosine residue
toplasm. Unphosphorylated rpS3 participates in ribosome biogenesis while phosphory-
404 T.-S. Kim et al. / Biochimica et Biophysica Acta 1793 (2009) 395–405nucleus, unphosphorylated rpS3 is assembled in the ribosome
whereas phosphorylated rpS3 is accumulated in the nucleus to repair
the damaged DNA.
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